Current Knowledge About the Effect of Nutritional Status, Supplemented Nutrition Diet, and Gut Microbiota on Hepatic Ischemia-Reperfusion and Regeneration in Liver Surgery

Overview

Journal Nutrients

Date 2020 Jan 25

PMID 31973190

Citations 27

Authors

Maria Eugenia Cornide-Petronio

Ana Isabel Alvarez-Mercado

Monica B Jimenez-Castro

Carmen Peralta

Affiliations

Soon will be listed here.

Abstract

Ischemia-reperfusion (I/R) injury is an unresolved problem in liver resection and transplantation. The preexisting nutritional status related to the gut microbial profile might contribute to primary non-function after surgery. Clinical studies evaluating artificial nutrition in liver resection are limited. The optimal nutritional regimen to support regeneration has not yet been exactly defined. However, overnutrition and specific diet factors are crucial for the nonalcoholic or nonalcoholic steatohepatitis liver diseases. Gut-derived microbial products and the activation of innate immunity system and inflammatory response, leading to exacerbation of I/R injury or impaired regeneration after resection. This review summarizes the role of starvation, supplemented nutrition diet, nutritional status, and alterations in microbiota on hepatic I/R and regeneration. We discuss the most updated effects of nutritional interventions, their ability to alter microbiota, some of the controversies, and the suitability of these interventions as potential therapeutic strategies in hepatic resection and transplantation, overall highlighting the relevance of considering the extended criteria liver grafts in the translational liver surgery.

Citing Articles

Diet quality and physical activity affect metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction and etiology-associated steatohepatitis, and compensated advanced chronic liver disease among United States adults: NHANES....

Wang P, Xia B, Wang S Front Nutr. 2025; 11():1505970.

PMID: 39845917 PMC: 11750654. DOI: 10.3389/fnut.2024.1505970.

Current progress on the microbial therapies for acute liver failure.

Huang J, Xu T, Quan G, Li Y, Yang X, Xie W Front Microbiol. 2024; 15:1452663.

PMID: 39479215 PMC: 11521890. DOI: 10.3389/fmicb.2024.1452663.

Liver Extracellular Vesicles and Particles Enriched β-Sitosterol Effectively Promote Liver Regeneration in Mice.

Gongye X, Xia P, Ma T, Chai Y, Chen Z, Zhu Y Int J Nanomedicine. 2024; 19:8117-8137.

PMID: 39139504 PMC: 11319097. DOI: 10.2147/IJN.S465346.

Gut Microbiota and Liver Regeneration: A Synthesis of Evidence on Structural Changes and Physiological Mechanisms.

Kiseleva Y, Zharikova T, Maslennikov R, Temirbekov S, Olsufieva A, Polyakova O J Clin Exp Hepatol. 2024; 14(6):101455.

PMID: 39035190 PMC: 11259939. DOI: 10.1016/j.jceh.2024.101455.

Lactobacillus reuteri mitigates hepatic ischemia/reperfusion injury by modulating gut microbiota and metabolism through the Nrf2/HO-1 signaling.

Zhang L, Gong X, Tan J, Zhang R, Li M, Liu C Biol Direct. 2024; 19(1):23.

PMID: 38500127 PMC: 10946149. DOI: 10.1186/s13062-024-00462-5.

References

Yao H, Fu X, Zi X, Jia W, Qiu Y . Perioperative oral supplementation with fish oil promotes liver regeneration following partial hepatectomy in mice via AMPK activation. Mol Med Rep. 2017; 17(3):3905-3911. DOI: 10.3892/mmr.2017.8362. View

Vasco M, Paolillo R, Schiano C, Sommese L, Cuomo O, Napoli C . Compromised nutritional status in patients with end-stage liver disease: Role of gut microbiota. Hepatobiliary Pancreat Dis Int. 2018; 17(4):290-300. DOI: 10.1016/j.hbpd.2018.06.004. View

Bachellier P, Rosso E, Pessaux P, Oussoultzoglou E, Nobili C, Panaro F . Risk factors for liver failure and mortality after hepatectomy associated with portal vein resection. Ann Surg. 2011; 253(1):173-9. DOI: 10.1097/SLA.0b013e3181f193ba. View

Michail S, Lin M, Frey M, Fanter R, Paliy O, Hilbush B . Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease. FEMS Microbiol Ecol. 2015; 91(2):1-9. PMC: 4358749. DOI: 10.1093/femsec/fiu002. View

Gracia-Sancho J, Villarreal Jr G, Zhang Y, Yu J, Liu Y, Tullius S . Flow cessation triggers endothelial dysfunction during organ cold storage conditions: strategies for pharmacologic intervention. Transplantation. 2010; 90(2):142-9. PMC: 4522158. DOI: 10.1097/TP.0b013e3181e228db. View

Elwyn D, Kinney J, Askanazi J . Energy expenditure in surgical patients. Surg Clin North Am. 1981; 61(3):545-56. DOI: 10.1016/s0039-6109(16)42436-9. View

Ito T, Nakamura K, Kageyama S, Korayem I, Hirao H, Kadono K . Impact of Rifaximin Therapy on Ischemia/Reperfusion Injury in Liver Transplantation: A Propensity Score-Matched Analysis. Liver Transpl. 2019; 25(12):1778-1789. PMC: 6887108. DOI: 10.1002/lt.25633. View

Senkal M, Mumme A, Eickhoff U, Geier B, Spath G, Wulfert D . Early postoperative enteral immunonutrition: clinical outcome and cost-comparison analysis in surgical patients. Crit Care Med. 1997; 25(9):1489-96. DOI: 10.1097/00003246-199709000-00015. View

Isabel Alvarez-Mercado A, Navarro-Oliveros M, Robles-Sanchez C, Plaza-Diaz J, Saez-Lara M, Munoz-Quezada S . Microbial Population Changes and Their Relationship with Human Health and Disease. Microorganisms. 2019; 7(3). PMC: 6463060. DOI: 10.3390/microorganisms7030068. View

10.

Cabre E, Periago J, Abad-Lacruz A, Gonzalez-Huix F, Gonzalez J, Esteve-Comas M . Plasma fatty acid profile in advanced cirrhosis: unsaturation deficit of lipid fractions. Am J Gastroenterol. 1990; 85(12):1597-604. View

11.

Bifari F, Nisoli E . Branched-chain amino acids differently modulate catabolic and anabolic states in mammals: a pharmacological point of view. Br J Pharmacol. 2016; 174(11):1366-1377. PMC: 5429325. DOI: 10.1111/bph.13624. View

12.

Stickel F, Hoehn B, Schuppan D, Seitz H . Review article: Nutritional therapy in alcoholic liver disease. Aliment Pharmacol Ther. 2003; 18(4):357-73. DOI: 10.1046/j.1365-2036.2003.01660.x. View

13.

Xie Y, Chen H, Zhu B, Qin N, Chen Y, Li Z . Effect of intestinal microbiota alteration on hepatic damage in rats with acute rejection after liver transplantation. Microb Ecol. 2014; 68(4):871-80. DOI: 10.1007/s00248-014-0452-z. View

14.

de Meijer V, Kalish B, Puder M, IJzermans J . Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection. Br J Surg. 2010; 97(9):1331-9. DOI: 10.1002/bjs.7194. View

15.

Gracia-Sancho J, Casillas-Ramirez A, Peralta C . Molecular pathways in protecting the liver from ischaemia/reperfusion injury: a 2015 update. Clin Sci (Lond). 2015; 129(4):345-62. DOI: 10.1042/CS20150223. View

16.

Kim H, Hong M, Choi H, Moon H, Lee H . Chemopreventive effects of korean red ginseng extract on rat hepatocarcinogenesis. J Cancer. 2015; 6(1):1-8. PMC: 4278909. DOI: 10.7150/jca.10353. View

17.

Qin N, Yang F, Li A, Prifti E, Chen Y, Shao L . Alterations of the human gut microbiome in liver cirrhosis. Nature. 2014; 513(7516):59-64. DOI: 10.1038/nature13568. View

18.

Gemperlein K, Dietrich D, Kohlstedt M, Zipf G, Bernauer H, Wittmann C . Polyunsaturated fatty acid production by Yarrowia lipolytica employing designed myxobacterial PUFA synthases. Nat Commun. 2019; 10(1):4055. PMC: 6731297. DOI: 10.1038/s41467-019-12025-8. View

19.

Ferrere G, Wrzosek L, Cailleux F, Turpin W, Puchois V, Spatz M . Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice. J Hepatol. 2016; 66(4):806-815. DOI: 10.1016/j.jhep.2016.11.008. View

20.

Page A, Ejaz A, Spolverato G, Zavadsky T, Grant M, Galante D . Enhanced recovery after surgery protocols for open hepatectomy--physiology, immunomodulation, and implementation. J Gastrointest Surg. 2014; 19(2):387-99. DOI: 10.1007/s11605-014-2712-0. View